Inadequate or delayed diagnosis of STIs can have serious consequences. It increases the risk of complications, promotes further transmission of infections, and leads to more advanced disease states. The lack of sensitive testing methods hampers the accurate identification of pathogens, especially in low concentration cases. This not only impedes effective treatment but also fuels the growing concern of antibiotic resistance. The societal stigma surrounding STIs further exacerbates the problem, discouraging patients from seeking timely help.
CoreBioLabs uses advanced molecular identification techniques, with the QuantStudio 12 Flex by ThermoFisher®. We proudly offer an option for in-house Antibiotic Susceptibility Testing. After positive culture growth, our BD Phoenix® system provides antimicrobial concentrations for detection of emerging resistance.
Resistance Markers:
CoreBioLabs rises to the challenge of STI diagnostics with our advanced PCR testing services. We’ve crafted a solution that not only meets but exceeds the demands of modern STI testing:
At CoreBioLabs, we offer a groundbreaking solution with our PCR testing services for STIs, tailored to overcome these diagnostic challenges:
Proactive Screening in High-risk Populations: Regular PCR screening in high-risk groups aids in early detection and treatment, enhancing community health outcomes.
Join us at CoreBioLabs in transforming the landscape of STI diagnosis and treatment. Our PCR testing services bring precision, sensitivity, and rapid results to the forefront, paving the way for improved patient care and public health. Choose CoreBioLabs for a future where every STI diagnosis is timely, accurate, and treated effectively.